NHI

Real Estate

National Health Investors, Inc. · REIT - Healthcare Facilities · $4B

UQS Score — Balanced Preset
54.5
Average

National Health Investors, Inc. scores 54.5/100 using the Balanced preset.

78.9
Quality
35%
43.0
Moat
30%
26.8
Growth
20%
62.3
Risk
15%

NHI — Key Takeaways

✅ Strengths

National Health Investors, Inc. shows strong profitability and capital efficiency
National Health Investors, Inc. shows conservative financial structure with manageable risk
National Health Investors, Inc. shows attractive valuation relative to fundamentals

⚠️ Areas of Concern

National Health Investors, Inc. has limited growth momentum

NHI — Score History

45505560Apr 2Apr 3Apr 4Apr 5Apr 6Apr 7Apr 8
DateUQSQualityMoatGrowthRiskValueChange
Apr 8, 202654.578.943.026.862.362.2-0.1
Apr 7, 202654.679.143.026.862.362.20.0
Apr 6, 202654.679.143.026.862.362.20.0
Apr 5, 202654.679.143.026.862.362.2+4.1
Apr 4, 202650.561.243.041.145.262.7-0.1
Apr 3, 202650.661.543.041.145.262.90.0
Apr 2, 202650.661.543.041.145.262.9

NHI — Pillar Breakdown

Quality

78.9/100 (25%)

National Health Investors, Inc. demonstrates outstanding capital efficiency and profitability, placing it among the highest-quality businesses in the market.

Return on EquityModerate

Profitability relative to shareholders' equity.

Operating ProfitabilityStrong

Ability to convert revenue into operating profit.

Net ProfitabilityStrong

Bottom-line profit as a share of revenue.

Cash GenerationModerate

Free cash flow relative to market value.

Growth

26.8/100 (20%)

National Health Investors, Inc. faces growth headwinds with declining or stagnant revenue trends.

Recent Revenue TrendModerate

Revenue trajectory over the last twelve months.

3Y Revenue CAGRWeak

Compound annual revenue growth rate over 3 years.

EPS GrowthWeak

Year-over-year earnings per share growth.

Forward Revenue OutlookWeak

Analyst consensus for future revenue growth.

Forward EPS GrowthModerate

Analyst consensus for future earnings growth.

Risk

62.3/100 (15%)

National Health Investors, Inc. maintains a reasonable risk profile with manageable debt levels.

Debt/EquityStrong

Total debt relative to shareholder equity.

Current RatioStrong

Short-term liquidity — ability to pay near-term obligations.

Interest CoverageWeak

Earnings capacity relative to interest payments.

Valuation

62.2/100 (15%)

National Health Investors, Inc. trades at a reasonable valuation with decent earnings yield and FCF multiples.

Earnings YieldModerate

Inverse of forward P/E — higher yield means cheaper stock.

Price to Free Cash FlowStrong

How many years of FCF the market cap represents.

PEG RatioModerate

P/E relative to earnings growth — lower is more attractive.

Moat

43/100 (30%)

National Health Investors, Inc. possesses some competitive advantages but faces meaningful competition. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for NHI.

Score Composition

Quality
78.9×25%19.7
Growth
26.8×20%5.4
Risk
62.3×15%9.3
Valuation
62.2×15%9.3
Moat
43.0×30%12.9
Total
54.5Average

Unlock Full NHI Analysis

Sign in to access detailed financial metrics, interactive price charts, custom pillar weights, 6 investor presets, and watchlist tracking.

✓ Detailed ratios✓ Price chart✓ Custom moat ratings✓ 6 investor presets✓ Watchlist
Analyze NHI in Detail →

More Stock Analysis

How is the NHI UQS Score Calculated?

The UQS (Unified Quality Score) for National Health Investors, Inc. is calculated using a proprietary 5-pillar framework with 25 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector.

Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.

Moat (25%) assesses National Health Investors, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.

Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.

Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.

Valuation (15%) measures whether National Health Investors, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.

Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.